Overview
Marc Theroux is a primary care provider, practicing in Internal Medicine in Fall River, Massachusetts. Dr. Theroux is rated as an Experienced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are High Cholesterol, Anemia, Childhood Iron Deficiency Anemia, and Multiple Myeloma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Beth Israel Deaconess Medical Center - Hematology/Oncology
Deepa Rangachari is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Rangachari is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Her top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Thymectomy.
Beth Israel Deaconess Medical Center - Hematology/Oncology
Daniel Costa is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Costa is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.
The General Hospital Corporation
Catherine Meador is a primary care provider, practicing in Internal Medicine in Boston, Massachusetts. Dr. Meador is rated as an Advanced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Her top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, EGFR Positive Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- High CholesterolDr. Theroux isDistinguished. Learn about High Cholesterol.
- Advanced
- AnemiaDr. Theroux isAdvanced. Learn about Anemia.
- AsbestosisDr. Theroux isAdvanced. Learn about Asbestosis.
- Ataxia-TelangiectasiaDr. Theroux isAdvanced. Learn about Ataxia-Telangiectasia.
- Childhood Iron Deficiency AnemiaDr. Theroux isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Chronic CoughDr. Theroux isAdvanced. Learn about Chronic Cough.
- CirrhosisDr. Theroux isAdvanced. Learn about Cirrhosis.
- Experienced
- Achilles Tendon RuptureDr. Theroux isExperienced. Learn about Achilles Tendon Rupture.
- Acute Eosinophilic PneumoniaDr. Theroux isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Interstitial PneumoniaDr. Theroux isExperienced. Learn about Acute Interstitial Pneumonia.
- Acute Kidney FailureDr. Theroux isExperienced. Learn about Acute Kidney Failure.
- AgranulocytosisDr. Theroux isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Theroux isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.